Ask the Author: Understanding Medication Compounding Issues
The AORN Journal is pleased to announce the fifth author Q&A on ORNurseLink!
From April 14-18, Rodney W. Hicks, PhD, RN, FNP-BC, FAAN, FAANP, author of “Understanding Medication Compounding Issues,” will be available on ORNurseLink to answer your questions or comments regarding guidelines and practices that aim to reduce potential contamination that can occur during the sterile compounding process. Simply click “Reply” to this post to submit a question or comment and he will respond within a 24-hour period.
The potential for contamination of compounded products and the resulting infections are a serious threat to patient safety. Immediate use products are used frequently in the perioperative department, and perioperative nurses should be familiar with compounding guidelines and practices. Take advantage of this exclusive opportunity to learn critical insights related to the four common elements of successful compounding: quality (eg, product identification, purity), the environment (eg, using a segregated compounding area), personnel activities (eg, following expiration dates), and the control process (eg, process monitoring).
We will also be sharing results of the medication compounding survey that was included in last week’s email that announced the author Q&A. Rodney will be revealing and addressing the survey results throughout the week, so please check back to find out how your knowledge of compounding compares to your perioperative colleagues.
Below are the survey questions that will be discussed during the Q&A:
1. Are you familiar with your organization's policies and procedures for compounding?
2. Do you utilize an in-house provider (eg, pharmacy) or an external third party for compounded medications?
3. Have you received training on handling compounded products either from the pharmacy department or the third party?
4. Are you familiar with guidelines for performing hand hygiene between handling each product?
5. Are you aware of disinfection requirements prior to compounding in an area where there is a high touch surface?
AORN members can access the “Understanding Medication Compounding Issues” article online or in the April print issue beginning on page 466.
quoted from here
From April 14-18, Rodney W. Hicks, PhD, RN, FNP-BC, FAAN, FAANP, author of “Understanding Medication Compounding Issues,” will be available on ORNurseLink to answer your questions or comments regarding guidelines and practices that aim to reduce potential contamination that can occur during the sterile compounding process. Simply click “Reply” to this post to submit a question or comment and he will respond within a 24-hour period.
The potential for contamination of compounded products and the resulting infections are a serious threat to patient safety. Immediate use products are used frequently in the perioperative department, and perioperative nurses should be familiar with compounding guidelines and practices. Take advantage of this exclusive opportunity to learn critical insights related to the four common elements of successful compounding: quality (eg, product identification, purity), the environment (eg, using a segregated compounding area), personnel activities (eg, following expiration dates), and the control process (eg, process monitoring).
We will also be sharing results of the medication compounding survey that was included in last week’s email that announced the author Q&A. Rodney will be revealing and addressing the survey results throughout the week, so please check back to find out how your knowledge of compounding compares to your perioperative colleagues.
Below are the survey questions that will be discussed during the Q&A:
1. Are you familiar with your organization's policies and procedures for compounding?
2. Do you utilize an in-house provider (eg, pharmacy) or an external third party for compounded medications?
3. Have you received training on handling compounded products either from the pharmacy department or the third party?
4. Are you familiar with guidelines for performing hand hygiene between handling each product?
5. Are you aware of disinfection requirements prior to compounding in an area where there is a high touch surface?
AORN members can access the “Understanding Medication Compounding Issues” article online or in the April print issue beginning on page 466.
quoted from here
No comments:
Post a Comment